Denali Advisors LLC
- SEC CIK
- 0001142941
- Latest filing
- Aug 10, 2026
RVNC holding history
Revance Therapeutics, Inc. in every 13F filed by Denali Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RVNC overviewAll 13F holders of RVNCFull Q2 2026 holdings
- Shares (Q4 2023)
- 0
- Sold out in Q4 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2023 | 0 | $0 | 0.0% | −1,100−100.0% | Sold out | Holders |
| Q3 2023 | 1,100 | $12.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 1,100 | $27.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 1,100 | $35.4K | <0.1% | −1,200−52.2% | Reduced | Holders |
| Q4 2022 | 2,300 | $42.5K | <0.1% | −2,200−48.9% | Reduced | Holders |
| Q3 2022 | 4,500 | $122.0K | 0.1% | −1,000−18.2% | Reduced | Holders |
| Q2 2022 | 5,500 | $76.0K | <0.1% | −1,000−15.4% | Reduced | Holders |
| Q1 2022 | 6,500 | $127.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 6,500 | $106.0K | <0.1% | +6,500 | New | Holders |